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Abstract
Introduction: Spinal surgeries are among the top procedures responsible for the highest degree
of post-surgical pain. Opioids are the mainstay of current pain management practices in the postoperative period. In light of the opioid epidemic, increased opioid tolerance, and changes in
legislation, there is a calling for alternative strategies in managing acute and chronic pain. The
purpose of this project is to answer the following question: Does implementation of an evidencebased intervention for preoperative administration of gabapentin reduce patients’ perception of
pain and reduce opioid consumption in those who experience lumbar spine surgery?
Objectives: The goal of this project is to evaluate the impact of preoperative gabapentin on
patient reported pain while reducing the number of opioids required post-operatively in lumbar
spine surgery patients. Reduction in opioid requirements may limit side effects common to
opioids including urinary retention, sedation, and nausea.
Methods: This quality improvement project was implemented with the neurosurgical team at a
hospital in the Midwestern United States. Gabapentin was administered to patients who are
gabapentin naïve approximately one hour prior to lumbar spine surgery. Patient reported pain,
opioid use, length of stay, adverse effects, and readmissions were compared pre and post
implementation to determine effectiveness of preoperative gabapentin administration.
Results: Expected results include improvement in patient perception of pain, reduction in opioid
use, fewer adverse effects, shorter length of stay, and fewer readmissions for pain control.
Conclusions: Gabapentin may be effective in reducing patient perceptions of pain and opioid
requirements following lumbar spine surgery. Further study with larger sample sizes are needed.
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Implications: Gabapentin should continue to be administered preoperatively to patients prior to
lumbar spine surgery to improve pain, reduce opioid requirements and improve post-operative
adverse effects.

Implementation of an Evidenced-Based Intervention for Pain Management in
Lumbar Spine Surgery
Introduction
The use of opioid medications for acute and chronic pain management has grown
exponentially in recent years, leading to unprecedented rates of substance abuse, overdose, and
death (National Institute on Drug Abuse [NIDA], 2018). Currently this opioid epidemic results in
an estimated 115 American deaths every day from opioid overdose, with prescription opioid
misuse costing the United States 78.5 billion dollars each year on healthcare costs, loss of
productivity, treatment for addiction, and criminal justice costs (NIDA, 2018). National attention
has been brought to the opioid epidemic as medications such as hydrocodone, oxycodone, and
morphine prescribed by healthcare providers for management of acute and chronic pain has led
to misuse. Recent changes in legislation now limit prescribing of opioid medications in
outpatient and inpatient settings. Restricting opioid prescribing will significantly impact how
acute care providers manage post-operative acute pain.
Currently acute care hospitals are challenged in treating acute pain following surgical
procedures for a multitude of reasons. Post-operative pain can be complicated by complex
procedures, patient co-morbidities, and pre-existing opioid tolerance. Following neurological
spine surgeries, it is common for patients to be discharged with a prescription for an opioid
medication for acute pain (Kurd, Kreitz, Schroeder, & Vaccaro, 2017). Recent studies have
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shown that 30-60% of patients continue to use opioids after the acute phase of healing following
spine surgery (Deyo et al., 2018). The acute phase of healing lasts three to four months
depending on evidence of bone healing on x-ray (North American Spine Society, 2018). Opioid
use preoperatively is a major predictor of long-term post-operative opioid use with many patients
requiring at least a 10% increase in dosage (Deyo et al., 2018). Opioid naïve patients are at
substantial risk of becoming a long-term opioid user with more patients receiving long-term
opioids after spine surgery than before surgery (Deyo et al., 2018). The cumulative dose of
opioids prescribed in the first 30 days after surgery strongly predicts long-term post-operative
opioid use (Deyo et al., 2018). Seeking alternative strategies to manage acute post-operative pain
is essential.
Spine surgeries are among the top six procedures responsible for the highest degree of
post-surgical pain (Bajwa & Haldar, 2015). Approximately up to 50% of patients experience
inadequate pain control leading to dissatisfaction and poor mobility, while almost 25% are given
excessive opioids resulting in suboptimal outcomes and adverse events (Rivkin & Rivkin, 2014).
The inflammatory cascade and resulting post-operative pain begin before the patient wakes up
from surgery (Rivkin & Rivkin, 2014). Therefore, strategies in managing acute post-operative
pain should be implemented prior to the onset of the activation of these various pain
mechanisms. Pre-emptive analgesia can be defined as administration of pain medication in the
perioperative period with the purpose of providing a preventive effect against pain via inhibition
of central autonomic activity (Devin & McGirt, 2015). Effective perioperative pain control is
associated with improved surgical outcomes, reduced hospital length of stay, and decreased
development of new chronic pain conditions (Devin & McGirt, 2015).
Opiate pain medications have been the mainstay of treatment for post-operative pain in
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spinal surgery. Although effective for acute pain, opioid use has shown to prolong hospital
length of stay related to side effects including respiratory depression, sedation, post-operative
nausea and vomiting, urinary retention, and ileus (Tan, Law, & Gan, 2015). Adverse events
related to opioid use also drives up medical costs and increases readmission rates (Tan et al.,
2015). In fact, inadequate pain control is the second most common reason for 30-day
readmissions following lumbar spine surgery (Kurd et al., 2017). Adequately managed pain
improves functional outcomes, leads to early ambulation, early discharge, and prevents the
development of chronic pain (Bajwa & Haldar, 2015). Unfortunately, treatment strategies in this
patient population are complex, as many already suffer from pre-existing chronic pain with long
term consumption of analgesics and opioids, altering pain perceptions in these patients (Bajwa &
Haldar, 2015).
Over the past decade, multimodal approaches to post-operative pain management have
been investigated. Use of opiate pain medication is effective in initially controlling acute pain,
but subsequent tolerance and a reduction in pain threshold develop rapidly resulting in an opioidinduced hyperalgesia (Tan et al., 2015). This hypersensitivity to pain and tolerance to
medications requires even higher doses of opiate medications, worsening the potential for
adverse effects from opioid use and further increases sensitivity to pain. Enhanced Recovery
After Surgery (ERAS) programs have been developed to address factors that delay postoperative recovery and prolong hospital stay, including pain management (Tan et al., 2015).
Research in this area has shown that multimodal analgesia, using more than one analgesic
modality, is effective in achieving pain control while limiting opioid-related side effects (Tan et
al., 2015). In spine surgeries, ERAS multimodal nonopioid analgesics used in the perioperative
stage include various combinations of medications including gabapentin, pregabalin,

IMPLEMENTATION OF AN EVIDENCED-BASED

8

acetaminophen, dexamethasone, ketamine, and nonsteroidal anti-inflammatory drugs (Rivkin &
Rivkin, 2014). These medications, used pre-emptively, act to inhibit central autonomic
hyperactivity, thus preventing pain (Ali et al., 2018). Because standard ERAS protocols for preemptive analgesia are multimodal, it is difficult to determine the benefits and adverse effects for
each combination of medicines used (Tan et al., 2015).
Gabapentin is a second-generation anticonvulsant medication used to treat chronic
neuropathic pain by binding to the α-2-δ subunit of N-type voltage-gated calcium channels to
inhibit neurotransmitter release and reduce neuronal excitability while sparing normal
physiologic pain transmission (Devin & McGirt, 2015). The effect of gabapentin is most
pronounced after nerve or tissue injury (Devin & McGirt, 2015). Common side effects of
gabapentin include dizziness, somnolence, fatigue, and ataxia (Epocrates, 2018).
Contraindications include hypersensitivity to gabapentin, renal impairment, and alcohol or drug
abuse (Epocrates, 2018). Drug interactions may occur with other central nervous system
depressant medications resulting in an enhanced effect (Epocrates, 2018). Preoperative
gabapentin has been integrated into ERAS programs as one intervention within the multimodal
approach to improve pain control and limit reliance on opioid use. Pre-emptive multimodal
analgesia including gabapentin has demonstrated improvement in acute post-operative pain,
activity, depression and anxiety, and self-care while reducing opioid use at two weeks following
surgery (Ali et al., 2018). The purpose of this quality improvement project is to implement an
evidence-based intervention utilizing preoperative gabapentin that has shown to reduce opioid
consumption and improve patients’ perception of pain in the first 24 hours post lumbar spine
surgery. Effective quality improvement is best achieved if organizational context are considered,
therefore, in the next section an assessment of the organization is discussed.
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Assessment of the Organization
An organizational assessment is a systematic process for evaluating the current state of an
organization regarding performance, and the factors that affect that performance (Better
Evaluation, 2018). The goal is to identify risks and challenges faced by the organization that
impacts their future success and performance (Universalia, 2018). The purpose of this
organizational assessment is to examine the current state of a West Michigan neurosurgery
program. The focus of this organizational assessment is to analyze the present pain management
strategies of the neurosurgery program, identify if a gap exists within the organization, present
data supporting the need for evidence-based practice change, and state the clinical problem
identified. Information was gathered utilizing an organizational framework and SWOT analysis
tool to ensure a comprehensive assessment was completed. The Institutional and Organizational
Assessment Model (IOA Model) was used to conduct the organizational assessment of the
neuroscience program (see Appendix A, figure 1).
Framework for Assessment
The IOA Model analyzes organizational performance by examining the macro and micro
underlying forces that drive the organization’s performance including four components: external
environment, motivation, and capacity (Universalia, 2018). The approach to the IOA Model
further identifies factors within external environment, motivation, and capacity that impact the
overall performance of the organization (Universalia, 2018). Each of these components are
affected by each other, as a change in one area will impact the overall organizational
performance.
External Environment. The external environment has had significant influence over the
neurosurgery program at the macro-level in the past year. Like the remainder of the U.S., in the
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midwestern United States, opioid overdoses increased by 70% from July 2016 through
September 2017 (NIDA, 2018). In response to this epidemic, Michigan Lieutenant Governor
Brian Calley signed legislation to combat opioid misuse and prevent addiction. As part of that
legislation, starting July 1, 2018, Public Act 251 limits the supply of an opioid prescription that
can be prescribed for acute pain to seven days (State of Michigan, 2017). Current practice at this
organization is to routinely prescribe an opiate and a benzodiazepine for longer than one week at
discharge from the hospital (X. XXXX, personal communication, May 25, 2018). In fact, the
clinic nurses (personal communication, May 25, 2018) report requesting physician assistants to
refill prescriptions for up to eight to ten weeks post lumbar fusion surgery. Some insurance
companies are also limiting the prescribing of opioid medications to one week, or 60 pills/month
(X. XXXX, personal communication, May 25, 2018). For example, Priority Health (2018) has a
quantity limit on short acting hydromorphone of 64 mg but does not limit quantities for
hydrocodone or oxycodone. Blue Cross Blue Shield of Michigan (2018) limits short acting
hydrocodone, hydromorphone, oxycodone, and codeine to a five-day supply for the first
prescription, then 30 days for subsequent refills. Medicare and Medicaid requirements on opioid
prescribing vary depending on the provider and have similar restrictions. The State of Michigan
(2017) also requires the provider to review the Michigan Automated Prescription System
(MAPS) on every patient prior to prescribing opioids and at each refill, allowing a seven-day
supply at a time for acute pain. Physician assistants and nurses in the outpatient neurosurgery
clinic have reported increased workload, reduced efficiency, disruption in workflow, and delayed
approval for prescription refills for patients (X. XXXX, personal communication, May 25,
2018). This recent change in the external environment has had direct impact on the practices in
pain management from the neurosurgery program, but conversely benefits patients from the
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adverse effects of opioid misuse such as somnolence, confusion, urinary retention, ileus,
respiratory depression and death (Devin & McGirt, 2015). Striving for improvement of health
outcomes for spinal surgery patients is the driving motivator for change.
Motivation. The motivations that drive the neurosurgery program are consistent with the
core values of the whole organization. The acute care hospital is a non-profit, faith-based health
care system that is a part of one of the largest multi-institutional health care delivery systems in
the United States (XXXXX XXXXXX, 2018c). Core values of the organization include
reverence (honoring the sacredness and dignity of each person), commitment to those who are
poor (serve those who are poor, especially the most vulnerable), justice (foster relationships to
promote the common good), stewardship (being accountable for the human, financial and natural
resources entrusted to our care), and integrity (faithful to who we say we are) (XXXXX
XXXXXX, 2018c). Guiding behaviors are reviewed at the beginning of each meeting within the
entire organization to remind the participants of the culture of the organization, and the purpose
of their work. The guiding behaviors include: “We support each other in serving our patients and
communities; we communicate openly, honestly, respectfully, and directly; we are fully present;
we are all accountable; we trust and assume goodness in intentions, we are continuous learners”
(XXXXX XXXXXX, 2018c). Following these guiding behaviors is observed in this organization
daily not only during department meetings, but also in collaborating with other departments,
casual conversations, and while delivering patient care. As a Magnet designated hospital,
shared decision making is common practice evidenced by various nurse led committees resulting
in changes utilizing evidence-based practice. An example includes initiating cryocuff use for
lumbar spine surgery patients post-operatively while hospitalized and allowing patients to take
the cryocuff home at discharge for continued use. Annual culture of safety scores obtained via
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the Press Ganey Agency for Healthcare Research and Quality (2018) survey reveal that staff are
content with their employment based on the overall culture of the organization to treat colleagues
and patients respectfully, and to do good for the health of the community.
Capacity. At the micro-level, the neurosurgery program has a solid organizational
structure in place. Department meetings, referred to as ‘Spine Team’, occur monthly and are
interdisciplinary consisting of leadership, neurosurgeons, physician assistants, registered nurses,
dietician, case managers, physical therapists, infection control, and pharmacists. At these
meetings, collected data is presented that tracks various indicators including number of surgeries,
infection rates, length of stay, readmissions, and complications. Further, the neurosurgery
program is a part of the Michigan Spine Surgery Improvement Collaborative (MSSIC). MSSIC
(2014) is a state-wide quality improvement collaborative of neurosurgeons and orthopedic
surgeons dedicated to improving quality of care and efficiency of treatment to better patient care
outcomes in spine surgery. Goals of MSSIC are to improve patient outcomes, reduce costs and
episodes of care, reduce complications, and minimize the rate of repeat surgeries (MSSIC, 2014).
Twenty-six Michigan hospitals are currently involved in the MSSIC project (MSSIC, 2014).
MSSIC is funded by Blue Cross Blue Shield of Michigan/Blue Care Network and tracks patients
who have cervical or lumbar surgeries before surgery and at 90 days, 12 months, and 24 months
in a patient registry (XXXXX XXXXXX, 2018b). Quarterly state-wide meetings are held to
discuss data findings and share strategies to improve outcomes across the hospitals (X. XXXX,
personal communication, May 31, 2018). Data collected is vast, consisting of complications,
opioid use, mobility, pre-existing conditions, etc. (X. XXXXX, personal communication, June 5,
2018). The data gathered is analyzed to see where improvements can be made to enhance patient
outcomes, reduce complications and costs, and improve quality of care (XXXXX XXXXXX,
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2018b).
The neurosurgery program collaborates well with other departments including anesthesia,
internal medicine, and palliative care. For patients with complex pain syndromes, palliative care
assists in pain medication management post-operatively. Complex pain syndromes are usually
seen in patients who were taking opioid pain medications prior to surgery. Chronic neuropathic
pain exacerbated by an acute surgical procedure often requires high doses of opioid medication
that are challenging to wean. Uncontrolled pain has been a complication that has prolonged
length of stay in the organization. Impaired mobility related to pain can lead to poor patient
outcomes and increases length of stay with a potential discharge to a rehabilitation center prior to
going home, causing higher healthcare costs. Longer length of stay has a negative impact on
hospital reimbursement from bundle payments. The palliative care team is helpful in alleviating
uncontrolled pain through daily consultation while the patient is hospitalized and provides a pain
plan and prescriptions upon discharge.
In January 2018, the neurosurgery program formed a subcommittee from Spine Team to
develop a neurological Enhanced Recovery after Surgery (ERAS) program. Mirrored after the
successful colorectal ERAS program, the neurological ERAS subcommittee is conducting a deep
dive investigation into how the neurosurgery program can continue to improve the care and
outcomes for their patients. The subcommittee is looking at best evidence to optimize patient
health before surgery, new strategies for intra-operative, and post-operative care. The ERAS is
looking at using Lean processes with evidence-based practice change to provide excellent care,
enhance the patient experience, and improve outcomes.
Overall Performance. The neurosurgery program is a designated Spine Center of
Excellence by Blue Cross Blue Shield and Priority Health that recognizes the program’s
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expertise and efficiency in delivering spine care (XXXXX XXXXXX, 2018d). Neurosurgical
procedures help maintain the financial viability of the organization through bundle payments
from insurance companies (X. XXXX, personal communication, May 31, 2018). There are also
financial incentives through MSSIC via pay for performance; if the neurosurgery program shows
improvement in outcome data, the hospital will be reimbursed accordingly (X. XXXX, personal
communication, May 31, 2018). According to the MSSIC data registry, the organization is
among the top-ranking hospitals when compared to other Michigan hospitals (X. XXXX,
personal communication, May 31, 2018). Although the neurosurgery program has performed
well, there are always ways to improve outcomes, and the team is continuously striving to
advance care.
Ethics and Protection of Human Subjects
An application for review and approval or exemption of this project was submitted to the
organization and to Grand Valley State University’s Institutional Review Board (IRB). Beyond
further planning, no project activities commenced until the review was completed and Board
approval or exemption was granted. The purpose and scope this project are limited to evidencebased practice improvement and quality improvement. Health Insurance Portability and
Accountability Act (HIPPA) privacy rules were upheld. No patient identifiable information was
collected. No physical, social, psychological, legal, or economic threats to patients are associated
with this project. The impact of the project posed minimal or no risk to participants. All members
of the team completed human subject’s protection training via the Collaborate Institute Training
Initiative (CITI) and their interactions with patients were guided accordingly.
Stakeholders
Identifying key stakeholders is imperative when completing an evidence-based practice
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change. A key stakeholder includes any person or persons who are critical to creating and
implementing a practice change, or who will be significantly affected by the practice change
(Hockenberry, Brown, & Rodgers, 2015). For assessing pain management in the neurosurgery
program, key stakeholders include healthcare providers (neurosurgeons, physician assistants),
registered nurses (inpatient and outpatient), pharmacists, neuroscience leadership (clinical nurse
specialist, performance improvement coordinator, neuroscience program manager), and patients.
The neurosurgeons must concede to the practice change and prescribe the medication, registered
nurses administer the medications and document pain scores/effectiveness of medications,
pharmacists assist in proper dosing and timing of medications, and the leadership team helps
collect and interpret data and provides progress reports presented at monthly Spine Team
meetings. Patients receive the medication for their pain and report its effectiveness. All key
stakeholders are essential to success of a practice change.
Strengths Weaknesses Opportunities and Threats Analysis
Imperative to any organizational assessment is a strength, weakness, opportunity, and
threat (SWOT) analysis. A SWOT analysis is another way to identify an organization’s internal
strengths and weaknesses, examine opportunities for growth, and determine threats from the
external environment (Harrison, 2010). Figure 2 in Appendix B shows the outcomes of the
SWOT analysis completed for the neurosurgery program and is explained below.
Strengths. Strengths are current factors that have generated exceptional organizational
performance (Harrison, 2010). For the neurosurgery program, the structure of the program is
already set up for process change, and tracking outcomes. Through Spine Team collaboration
with other departments, and participating in MSSIC, the neurosurgery department demonstrates
commitment to improving care of spine patients. Regarding pain management, the surgeons and
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physician assistants have communicated recognition of the opioid epidemic and verbalize
openness to evidence-based practice change in managing pain at department meetings. Palliative
care consultation has been utilized as needed during inpatient hospitalizations.
Weaknesses. Factors that potentially increase healthcare costs and reduce quality of
health care are considered weaknesses (Harrison, 2010). The neurosurgery team struggles with
managing acute pain in spine surgery patients, leading to high utilization of opioid medications.
Unfortunately, the palliative care team does not continue to follow patients after discharge from
the hospital after prescribing them opioid medications while hospitalized. There are also many
instances that patients require a longer length of stay due to uncontrolled pain, or due to poor
mobility related to inadequate pain control. This, in turn, affects the financial viability of the
hospital due to less income generated from bundle payments. Transfer to a rehabilitation center
at discharge increases overall healthcare costs for the patient.
Opportunities. Opportunities are described as new initiatives available to the health
organization such as collaborative networking and developing new healthcare programs or
protocols to improve quality and efficiency (Harrison, 2010). An opportunity for the
neurosurgery team is the recent development of the ERAS subcommittee. Since the colorectal
ERAS has been successful, it gives the neurosurgery program guidance into developing their
own program. There is opportunity within the ERAS to consider evidence-based practice change
of pain management strategies. With recent changes in Michigan legislation surrounding opioid
prescribing, there is opportunity to explore non-opioid interventions for pain management.
Patients will benefit by improved pain control in the acute phase of recovery leading to early
mobility and reduced post-operative complications related to uncontrolled pain and immobility.
The patient will report a better surgical experience and hospital stay, increasing patient
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satisfaction rates.
Threats. Factors that could negatively affect organizational performance are considered
threats (Harrison, 2010). One major threat in acute post-operative pain management in spine
surgery patients is the presence of chronic pain. Often patients are already on high doses of
opioid medications prior to surgery, which makes opioid weaning difficult. In particular,
neuropathic pain is common in spine surgery patients and is one of the most challenging types of
pain to control. Longer length of stay due to pain management leads to lost revenue for the
hospital. Threats to the neurosurgery program due to the recent legislative changes in opioid
prescribing include mandatory MAPS review prior to each prescription refill, and only allowing
refills for one week at a time. This is not time efficient for the physician assistants, causes delays
for patients receiving refills, and also affects efficiency of clinic and surgical work flow.
Clinical Practice Question
Accordingly, an evidence-based project to answer the following clinical practice questions
are proposed:
1. Does implementation of an evidence-based intervention for preoperative administration of
gabapentin reduce opioid consumption among persons undergoing lumbar spine surgery
for up to 24 hours post-operatively?
2. Does implementation of an evidence-based intervention for preoperative administration of
gabapentin improve patient’s perception of pain among persons undergoing lumbar spine
surgery for up to 24 hours post-operatively?
3. Does implementation of an evidence-based intervention for preoperative administration of
gabapentin reduce length of stay among persons undergoing lumbar spinal surgery?
Review of the Literature
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A review of the literature was conducted to examine the current evidence to support the
clinical practice questions. The formal appraisal of the literature and findings of the review are
discussed.
Method
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guideline served as the framework for this review (Moher, Liberati, Tetzlaff, Altman, &
PRISMA Group, 2009). A comprehensive electronic search was conducted in the CINAHL
database, PubMed, and Web of Science and was limited to reviews in the English language
during the period of 2013 to 2018. Keywords were gabapentin, spin*, preoperative, preventive,
and pre-emptive. Similar search terms preoperative, preventive, and pre-emptive were listed by
using Boolean operator OR, and the Boolean operator AND was used to narrow articles that are
relevant to the review. Spin* (wild card) was used to include words such as spine and spinal.
Inclusion/Exclusion Criteria. Included were articles that featured adults age 18 or older
who underwent any type of lumbar spine surgery such as laminectomy, discectomy, lumbar
fusion, etc. Articles that included any other surgical procedure or trauma related spine surgery
were excluded. Studies that involved preoperative administration of gabapentin as a solo
intervention were included. Those that did not give gabapentin as a pre-emptive medication were
excluded. Only meta-analysis and systematic reviews were included. Randomized controlled
trials were excluded from this review. Articles that were chosen for this review compared
preoperative gabapentin administration to placebo. One article contained a comparison of
gabapentin versus pregabalin versus placebo. This article was included in this literature review to
compare gabapentin to placebo and the pregabalin data was not used. Data on pregabalin is
outside the scope of this review. Included were outcomes on the efficacy of gabapentin in
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reducing pain scores, reducing opioid consumption, and reported adverse effects. Pain scores
were measured using the visual analog scale (VAS), opioid consumption was measured in
cumulative morphine equivalents consumed, and adverse effects were patient reported.
PRISMA
The search yielded a total of 145 articles. Forty-six duplicates were removed. Each
review was screened using inclusion and exclusion criteria according to PRISMA criteria with a
reduction of 87 articles (Moher et al., 2009) (see Appendix C, figure 3). Review of titles and
abstracts resulted in removal of 8 articles that did not meet the inclusion criteria. The remaining
4 articles were included in this review (see Appendix D, table 1). Two of the studies were metaanalysis and two were systematic reviews and meta-analysis. All together these reviews
represent 40 randomized control trials on preoperative gabapentin administration. All articles
were obtained from peer-reviewed journals.
Summary of Results
All four studies reported a statistically significant reduction in cumulative morphine
equivalents consumed. Han et al. (2017) found that reduction in cumulative morphine
equivalents was statistically significant at 24 hours at all doses of gabapentin, but there was a
positive correlation between dose of gabapentin and reduction of morphine. The patients who
received a 1200 mg dose of gabapentin saw the greatest reduction in opioid use (Han et al.,
2017).
Visual analog scores (VAS) were measured to quantify the efficacy of preoperative
gabapentin in reduction of reported pain. All four studies showed statistically significant lower
pain scores in patients receiving gabapentin versus placebo. Although VAS scores were
measured at different time intervals following surgery, results were consistently similar in all
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studies. Patient reported reduction in pain was greatest in the early hours following
administration, and as time went on the difference in pain scores between the gabapentin groups
and placebo lessened but were still statistically significant.
Adverse effects of preoperative gabapentin use were measured via patient self-report in
three of the studies (Han et al., 2017; Liu et al., 2017; Peng et al., 2017). The most commonly
reported adverse effects were nausea, vomiting, headache, dizziness, somnolence, pruritis, and
urinary retention. Patients who received preoperative gabapentin reported less vomiting and
pruritis in all three studies compared to those who did not receive gabapentin (Han et al., 2017;
Liu et al., 2017; Peng et al., 2017). Nausea was less frequently reported in the gabapentin group
in two studies (Liu et al., 2017; Peng et al., 2017). The incidence of urinary retention, dizziness,
and somnolence was less in patients who received preoperative gabapentin compared to usual
care (Han et al., 2017; Peng et al., 2017).
Several limitations of this literature review exist. First, the literature search yielded only
four articles within the final eligibility criteria. This is likely because research in the area of
gabapentin use is relatively recent (within the past 10 years), and future research is focused on a
multimodal approach to ERAS protocols without measuring the effectiveness of each
intervention separately. The varying doses of gabapentin presented in the review is also a
limitation, as this makes it difficult to translate evidence into practice. Also, none of the articles
address the concern on use of preoperative gabapentin in patients who are already taking this
medication for chronic neuropathic pain, which is quite common in the spine population (Wiffen
et al., 2017). Lastly, none of the articles address pain scores and opioid use for longer than 24
hours following surgery. This literature review suggests that the benefit from preoperative
gabapentin administration does not extend past the second post-operative day. However, it is
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common for spine surgery patients to require medication for severe pain beyond 24 hours
following surgery.
Evidence to be used for Project
Findings of this literature review suggest that administration of preoperative gabapentin
is beneficial in improving acute pain experienced by patients within the first 24 hours postoperatively following spine surgery. Further, preoperative gabapentin can assist in reducing the
number of opioids necessary to control severe post-operative pain. Adverse effects of gabapentin
use preoperatively are minimal. Overall, including gabapentin use in perioperative care of
patients undergoing spine surgery is safe and effective in improving surgery outcomes.
Determining the dose of gabapentin to administer is difficult to discern from this
evidence. Three of the studies compared randomized control trials that had varied doses of
gabapentin ranging from 300 mg-1200 mg (Han et al., 2017; Liu et al., 2017; Yu et al., 2013).
Findings suggested that higher doses of gabapentin (600 mg or higher) reflected less opioid use
(Han et al., 2017; Liu et al., 2017; Yu et al., 2013). Peng and colleagues (2017) recommend the
dose of gabapentin to be at least 900 mg for best outcomes. Alternatively, higher doses of
gabapentin could place the patient at risk for side effects of the medication, especially if the
patient is gabapentin naïve. Overall, the literature is not clear on the most efficacious dose of
gabapentin as the findings were variable based on the studies. However, current evidence is
strong and consistent to support administration of preoperative gabapentin to lumbar spine
surgery patients.
Phenomenon Conceptual Model
The purpose of a conceptual model is to provide a framework to determine the
interventions required for an evidence-based practice change (Hockenberry et al., 2015). The
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conceptual model attempts to describe, explain, and/or predict a phenomenon (Hockenberry et
al., 2015). The Promoting Action on Research Implementation in Health Services Framework
(PARiHS) provides a conceptual map that identifies achievement of evidence-based practice
change depends on the planned behavior change of individuals, teams, and organizations (Dang
et al., 2015). Successful implementation is a function of three concepts: evidence, context, and
facilitation (Dang et al., 2015). A visual representation of the PARiHS framework is depicted in
Appendix E, figure 4. Successful implementation is based on the nature and type of evidence, the
qualities of the context that the evidence is introduced, and the way the process is facilitated
(Dang et al., 2015).
Evidence. Evidence is defined broadly to include knowledge from research, clinical
experience, patients and caregiver’s experience, and local context information (Dang et al.,
2015). The conceptualization of evidence for this project is high. Research evidence via literature
review indicates that preoperative gabapentin administration is beneficial for patients. Further,
MSSIC supports the use of preoperative gabapentin and is already implementing preoperative
gabapentin administration in other hospitals throughout Michigan. Preoperative gabapentin has
been a known successful pain management strategy in other surgical procedures including
orthopedics and gastroenterology.
Context. Context is defined as the environment or setting that the proposed change will
be implemented (Dang et al., 2015). Contextual factors that promote successful implementation
are also strong as demonstrated within the organizational assessment above. The culture of the
organization is such that there is decentralized decision-making evidenced by the formation of
Spine Team and ERAS. As a teaching hospital, the organization is conducive to change, and
strives to continue to improve care of the neurosurgical population.
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Facilitation. Facilitation is defined as the process of implementing the evidence-based
change into practice (Dang et al., 2015). Facilitation depends on performance of this doctoral
student the as a facilitator. Appropriate skills and knowledge to help the key stakeholders to
apply evidence into practice will be critical to implementation of this project. Flexibility,
patience, continuous learning and critical reflection by the facilitator are essential for success.
Project Plan
Purpose of Project and Objectives
The purpose of this DNP project is to implement an intervention of administration of
preoperative gabapentin, an evidence-based pain management practice, into standard of care for
lumbar spine surgeries. As part of the development of an ERAS program for all spine surgeries,
administration of preoperative gabapentin is an adjunct to current pain management practices.
Currently the only patients receiving gabapentin are the patients who take gabapentin as a part of
their home medications. The objectives of this project are to improve patient perceptions of pain,
reduce the number of opioids required in the first 24-hour post-operative period, reduce adverse
effects of opioid medications, and decrease length of stay post-operatively in patients undergoing
lumbar spine surgery.
Design for the Evidence-Based Initiative
This DNP project is a quality improvement project. A quality improvement project
translates current evidence into practice, rather than creating new research findings. Evidence for
improved outcomes with administration of preoperative gabapentin in lumbar spine surgeries is
well supported in literature. This DNP project seeks to improve pain management and related
outcomes utilizing best evidence-based practice strategies.
Setting
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The setting for this DNP project is a 283-bed acute care hospital in West Michigan. The
neurosurgery program is embedded within the larger hospital organization. The neuroscience
program comprises of three neurosurgeons, three physician assistants, and four registered nurses
in the outpatient clinic. Over 500 lumbar spine neurosurgeries are completed yearly (XXXXX
XXXXXX, 2018a). The 34-bed inpatient unit within the acute care hospital provides care for
patients post-operatively following neurosurgical procedures. The neurosurgery leadership team
includes a medical director of neurosurgery held by one of the three neurosurgeons, clinical
service director, neuroscience program manager, two performance improvement coordinators,
clinical nurse specialist, clinical nurse leader, and managers of the outpatient clinic and inpatient
nursing unit. The neurosurgery program closely collaborates with the surgical
department/anesthesia, physical therapy, infection control, palliative care, nutrition, and
pharmacy. Administrative approval from the organization to conduct the DNP project via the
Institutional Review Board (IRB) from the organization and the university has been approved
and is available upon request.
Participants
Participants in the DNP project are the neurosurgeons, neurosurgery physician assistants,
registered nurses in the pre-procedural services department and inpatient unit, and patients
undergoing lumbar spine surgery. The physician assistants and neurosurgeons will be the
providers ordering the gabapentin, the pre-procedural registered nurses will be administering the
medication, the patients will receive the medication, and the inpatient registered nurses will
document patient response. Included in the project are patients age 18 and older having lumbar
spine surgery who are not already taking gabapentin prior to surgery (gabapentin naïve). Patients
excluded are those who are already taking gabapentin or pregabalin prior to surgery. Current
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practice for these patients is to take their home dose of gabapentin or pregabalin on the day of
surgery prior to hospital arrival. Also excluded are patients with chronic kidney disease stages
four and five as patients with a creatinine clearance below 30 mL/min cannot safely consume
more than 700 mg of gabapentin per day (Epocrates, 2018). Patients that have a clear
contraindication including gabapentin allergy and pregnancy are excluded.
Model Guiding Implementation
The model used to guide implementation is the Iowa Model of Evidence-Based Practice
to Promote Quality Care. The Iowa Model outlines a specific multiphase process for change with
feedback loops (see Appendix F, figure 5). The Iowa Model is ideal for this DNP project as it
can be easily adapted for use by multidisciplinary teams to problem-solve the steps of evidencebased practice change (Dang et al., 2015). The steps of the Iowa Model include the following:
identify triggers, organizational priorities, forming a team, evidence retrieval, critique and
synthesize the evidence, pilot the evidence-based practice change, and institute change in
practice (Dang et al., 2015).
Identify Triggers. Triggers help identify a clinical problem by questioning current
practice (Dang et al., 2015). Problem focused triggers identify an opportunity that needs
improvement while knowledge focused triggers come from new research findings that lead to
questions of current practice (Dang et al., 2015). Pain management in patients following lumbar
spine surgery has been chronically challenging for providers. New evidence on alternatives in
pain management in the literature provide evidence for an opportunity for practice change. Since
research shows other organizations have had success with this intervention, this project will
determine if this organization’s outcomes are consistent with what is found in the literature.
Organizational Priorities. Identifying an issue that is a priority for the organization is
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likely to gain support in carrying out the practice change (Dang et al., 2015). Alternatives in pain
management for spine surgery is an organizational priority in light of legislative changes, and
through the development of the ERAS program. This intervention also aligns with the
organizational priority of decreasing hospital length of stay and improving patient experience.
Acceptance for development of this DNP project is well supported by senior leadership and
members of the neurosurgical team.
Forming a Team. The next step is to form a team of stakeholders to research, develop,
implement, and evaluate the practice change (Dang et al., 2015). For this DNP project, the DNP
student formed an advisory team with the neuroscience clinical nurse specialist at the
organization and two university professors in March 2018. The DNP student is also a part of the
ERAS team and Spine Team at the organization since February 2018. The ERAS team formed in
January 2018 initially to explore trends in surgical site infections, then expanded to improve all
areas of neurosurgical spine care. Spine Team and ERAS meet monthly. The DNP project is one
important piece of the ERAS improvement work, which is a subcommittee of Spine Team.
Evidence Retrieval. A complete literature search was completed by the DNP student as
outlined in this document above. This evidence retrieval was completed throughout the summer
of 2018 with the formal literature review completed in August 2018.
Critique and Synthesize the Evidence. After gathering evidence from the literature,
findings were critiqued to create an evidence-based practice intervention for preoperative
administration of gabapentin in lumbar spine surgeries. Findings from the evidence suggest that a
single dose of 600-1200 mg of gabapentin one hour prior to surgery yields best results. Since the
dose was variable in the literature, an appropriate dose of gabapentin for this organization was
determined. Expert opinion was sought from a neuro-palliative care physician who agreed with
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the evidence found in the literature regarding proper dosing and recommended a 900 mg dose
with further recommendations concerning inclusion/exclusion criteria for patients with chronic
kidney disease and those who were not gabapentin naïve or prescribed pregabalin, as those
variables were not found in the literature (X. XXXXXXXX, personal communication, September
4, 2018). The pharmacist in the neurosurgery department also agreed with the 900 mg dose and
inclusion/exclusion criteria. This intervention is also consistent with standards used at other
MSSIC hospitals in Michigan.
Pilot the Evidence-Based Practice Change. Piloting an evidence-based practice change
allows for identifying potential issues in a controlled environment and allows comparison of preand post-pilot data to determine success and effectiveness of the intervention, providing
opportunity for modification before instituting a change in practice (Dang et al., 2015). A
colorectal surgeon spoke to the Spine Team regarding enhanced recovery guidelines in the
colorectal department during the June 2018 Spine Team meeting, and literature findings specific
to gabapentin use were presented by the DNP student at Spine Team during the July 2018
meeting. The neurosurgical physician assistants and neurosurgeons formally approved of this
project at the Spine Team meeting in September 2018. The physician assistants and
neurosurgeons have been educated during the Spine Team meeting in September 2018 by the
DNP student on the determined dose of 900 mg gabapentin one hour prior to surgery. After
obtaining approval from the organization’s IRB, a ‘go-live’ date for the pilot was selected for
December 1, 2018. The DNP student educated the registered nurses in the pre-procedural
services department and in the neurosurgery clinic, so they can anticipate the order from the
neurosurgeon and administer the medication appropriately. This education was disseminated
from the DNP student to the clinic nurses via a Lunch and Learn in November 2018, and a
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situation, background, assessment, recommendation (SBAR) communication tool explaining the
intervention was given (see Appendix G). The surgery clinical nurse specialist disseminated the
SBAR tool to the pre-procedural nurses and anesthesiologists in November 2018. The DNP
student was present in the clinic two weeks before the ‘go-live’ date as surgeries are typically
scheduled two weeks in advance. The DNP student was also present in the pre-procedural
services department during the first week of ‘go-live’ to ensure the intervention is occurring.
Institute Change in Practice. Evaluation of pre- and post-pilot data determined
integration of the evidence-based intervention into daily practice (Dang et al., 2015). Continued
monitoring and analysis of process and outcome data with feedback will promote sustained
integration of the change into practice (Dang et al., 2015). Dissemination of results of the DNP
project will be reported to the university and the organization. If it is found that gabapentin is
helpful in reducing pain, opioid use, and length of stay, this intervention may be expanded to use
in cervical spine surgeries. Additional preoperative medications will be added in the future to
develop a multimodal approach to pre-emptive pain management in patients receiving lumbar
spine surgery. Administration of preoperative gabapentin prior to lumbar spine surgery is
consistent with current evidence to help reduce the number of opioids consumed in the first 24
hours and improve patient perception of pain with fewer adverse effects.
Implementation Steps and Strategies
The steps for implementation of preoperative administration of gabapentin to lumbar
spine surgery patients are described. Evidence-based implementation strategies guided the steps
in completing this evidence-based quality improvement project.
1. Build a coalition prior to implementation on December 1, 2018 (Powell et at.,
2015). Relationships with key stakeholders have been established through
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participation in ERAS and Spine Team monthly meetings. Readiness for change
and potential barriers and facilitators are realized and are integrated into the
implementation steps.
2. Design an intervention and a process streamlined for preoperative administration
of gabapentin for lumbar spine surgery patients prior to September 26, 2018. The
intervention consists of administering 900 mg of gabapentin one hour prior to
surgery to lumbar spine surgery patients based on best evidence from the
literature. Excluding patients who are already prescribed gabapentin or
pregabalin, patients with a hypersensitivity, and those with stage four and five
chronic kidney disease is supported by expert opinion and gabapentin medical
reference Epocrates (2018).
3. Present intervention for evidence-based quality improvement intervention at
Spine Team meeting on September 26, 2018. Conduct local consensus discussion
with Spine Team members including physician assistants, neurosurgeons, and
pharmacist for approval of practice change (Powell et al., 2015). Spine Team
approved of this intervention at the September meeting.
4. Submission of evidence-based intervention to the organization and university IRB
by the DNP student prior to November 10, 2018. The organization’s IRB
approved this DNP project on November 13, 2018 and the university’s IRB
approval was obtained November 26, 2018. Approval letters from each respective
IRB are available upon request.
5. Conduct education to the neurosurgery clinic and pre-procedural services
department in November 2018 (Powell et al., 2015). The DNP student presented
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preoperative gabapentin education to the clinic nurses via a Lunch and Learn in
November 2018. The DNP student also disseminated the SBAR communication
tool to the clinic nurses and the pre-procedural services department via the
surgery CNS explaining the intervention in November 2018. The order for the
preoperative dose of gabapentin is to be hand written on the surgical boarding slip
completed by the clinic nurses and ordered by the physician starting December 1,
2018.
6. Aim for a ‘go-live’ date of December 1, 2018. Education and IRB approval were
both completed in November 2018 with implementation beginning December 1,
2018.
7. The DNP student reminded clinicians of the ‘go-live’ date and intervention for the
first week of implementation (Powell et al., 2015). The DNP student was present
in the neurosurgery clinic for two weeks prior to the ‘go-live’ date and in the preprocedural services department during the first week of implementation to provide
clinical supervision for neurosurgery clinicians and pre-procedural registered
nurses to answer questions and ensure implementation (Powell et al., 2015).
8. The DNP student gathered two months of patient data via chart review pre and
post-intervention implementation. A total of two months of data was an
obtainable number of subjects to allow for saturated data. Chart review began
after IRB approval for pre-implementation data and corresponding to the ‘go-live’
date for post-implementation data. Data was collected until February 7, 2019.
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9. The DNP student used a data expert consisting of a university statistician student
to analyze and interpret data findings (Powell et al., 2015). This occurred once all
the data is collected in February 2019.
10. The DNP student will disseminate findings from this evidence-based quality
improvement project by March 30, 2019. The DNP student will prepare a project
defense to present to the university and will relay clinical data to providers at the
Spine Team meeting in April 2019 (Powell et al., 2015). It is possible that the
outcomes from this DNP project be disseminated to the MSSIC organization
(Powell et al., 2015).
Measures
Many measures were collected during the implementation of this evidence-based project.
Protected health information was collected and stored securely. Data was collected by the DNP
student via chart review from the electronic health record. Demographic measures include
patient age, sex, type of surgery (laminectomy versus lumbar fusion), and history of prior lumbar
spinal surgery (yes or no). Whether the patient was already taking gabapentin/pregabalin and if a
preoperative dose of gabapentin was given was measured. Length of stay was measured by
number of minutes the patient spent on the inpatient unit of the hospital starting at transfer from
the post anesthesia recovery unit until discharge from the hospital. Discharge disposition was
categorized into a home discharge, or to a rehabilitation facility regardless if considered acute or
subacute.
Pain scores reported by patients were collected via the numeric rating scale. The numeric
rating scale is the scale most widely used in the organization to assess pain. The numeric rating
scale is proven to be reliable, valid, sensitive to change, and easy to administer for measuring
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acute severe pain (Bendinger & Plunkett, 2016). The numeric rating scale defines mild pain as a
score of one to three, moderate pain score four to six, and severe pain score seven to 10
(Bendinger & Plunkett, 2016). Each individual patient reported pain scores during the first 24
hours on the inpatient unit were collected. Opioid use in the first 24 hours of the post-operative
period on the inpatient unit was calculated and measured in total daily morphine milligram
equivalents (MME). This was calculated by the New York City Department of Health and
Mental Hygiene mobile application version 2.0.2. According to the Centers for Disease Control
and Prevention (CDC, 2018), calculating total daily dose of opioids identify those at higher risk
of overdose. Dosages at or greater than 50 MME/day have twice the risk of overdose compared
to those consuming less than 20 MME/day (CDC, 2018). Opioid tolerance has been defined in
the literature as consumption of at least 60 MME for more than seven days within the prior 14
days (Young, Lund, Dasgupta, & Funk, 2018). Opioid tolerance was measured as this will likely
affect the daily MME.
Potential complications from opioid and gabapentin use were assessed. Post-operative
urinary retention via tracking straight catheterizations, sedation via Pasero Opioid-induced
Sedation scores (POSS), and nausea via administration of antiemetics were measured during the
first 24 hours on the inpatient unit. The POSS has shown adequate validity and reliability to
measure level of sedation during opioid administration for pain management, is easy to use, and
is already used by the organization (Nisbet & Mooney-Cotter, 2009). A POSS score of S-2 is
considered acceptable, and a score of three or four unacceptable (see Figure 7).
Readmissions to the emergency department and inpatient unit within the first 30 days of
discharge related to pain and sedation were also measured. There is a trend within the
organizational data that patients return for pain control or complications from opioid use
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including hallucinations, injury from fall, altered mental status, and constipation. This project
closely monitored for changes in trends of readmissions related to opioid consumption or
overuse.
Data Collection Procedures
Data collection occurred by the DNP student at the organization. Data was collected from
the Cerner electronic health record. Pre-implementation data collection began once approval
from the organization’s IRB was obtained. The data elements that were collected during the data
collection period have been described above. The sample size of each group varied according to
the number of surgeries in the months of pre and post-implementation. Data was collected by the
DNP student and directly documented in the Research Electronic Data Capture (REDCap)
platform required from the organization. Data was then exported to statistical package for the
social sciences (SPSS) software for interpretation.
Data Management
Data was carefully managed to ensure confidentiality and security. Data collected from
the electronic health record was documented on a desktop computer provided by the organization
in the REDCap data collection tool documenting numbers only as defined in the data collection
tool dictionary. Data was also recorded on a paper copy of the data collection tool as a back-up
that was kept in the CNS’ locked office and will be destroyed at the completion of this project.
The DNP student’s computer and REDCap is password protected and is never alone in a public
area. The data was analyzed with SPSS software provided by the university’s graduate statistics
student. The data was organized within the SPSS software at the discretion of the graduate
statistics student to identify relationships among opioid use, perception of pain, and potential
adverse effects. Data was not accessible to persons other than the DNP student and the graduate
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statistics student but has been viewed by the members of the DNP student’s advisory team.
Analysis
The analysis of the data was completed with the assistance of the graduate statistics
student. Descriptive information on the patients are presented in the form of a table. Descriptive
statistics include age, sex, history of prior lumbar surgery, and presence of opioid tolerance. A
distribution of the variables, such as number of opioids used pre and post- implementation are
shown in a box plot or histogram, at the statistician student’s discretion. Length of stay, patient
reported pain scores, whether gabapentin was given, whether patient was already taking
gabapentin/pregabalin, discharge disposition, urinary retention, sedation, nausea, and
readmissions are also presented in this manner.
Analysis of the outcome data to test for significance between pre-implementation data
and post-implementation data was completed with assistance from the graduate statistics student.
Significance is reported using p-values. Categorical data was analyzed using Chi square or
Fisher’s exact test depending on if assumptions are met. Frequency and percent were reported.
Quantitative data were analyzed using independent two sample T-tests unless assumptions are
not met in which case Wilcoxon rank sum test was used. For the T-test the mean and standard
deviation were reported, or the median and interquartile range for the Wilcoxon rank sum test,
respectively. Data is displayed in a graph, chart, or table as appropriately determined by the
graduate statistics student. The data was analyzed to answer the clinical questions listed above to
determine if administration of preoperative gabapentin to lumbar spine surgery patients
improved pain and reduced opioid use without adverse effects.
Resources and Budget
The resources and budget required for this DNP project are minimal (see Appendix I).
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The majority of the cost for this project was donated by the DNP student as the project manager.
The DNP student donated time to create the implementation plan (8 hours), educate the providers
at Spine Team (1 hour), educate the neurosurgery clinic staff (1 hour), be present in the
neurosurgery clinic for two weeks prior to the ‘go-live’ date (5 hours), be present in the preprocedural services department for the first week following the ‘go-live’ date (5 hours), and
spent eight hours per week on chart reviews for eight weeks (64 hours). The DNP student is a
registered nurse with 13 years’ experience, therefore the hourly rate is calculated to be $30 per
hour (Payscale, 2018b). The total donated cost for the DNP student program manager is $2,520.
Since time invested by staff for education on the project occurred within the work day, there is
no additional cost for education.
Other resources and cost to consider are time investment by the neuroscience clinical
nurse specialist and the cost of gabapentin. The clinical nurse specialist assisted the DNP student
initially with the project design, implementation, and data collection strategies. This time did not
exceed three hours. The average hourly rate for a clinical nurse specialist is $40 per hour
(Payscale, 2018a). The cost by the organization for one 900 mg dose of gabapentin is $0.14 (X.
XXXXX, personal communication, September 13, 2018). With a sample size of 24 patients
receiving the gabapentin, the total cost of gabapentin is $3.36. The university cost for the
statistician is $100.
Potential cost savings for the organization is not completely known. With the
implementation of preoperative gabapentin, patients may require fewer opioid medications. The
organization’s cost of two tablets of Norco 10/325 is $0.38 per dose, and one milligram of
intravenous Dilaudid is $1.05 per dose (X. XXXXX, personal communication, September 13,
2018). If each patient requests one fewer doses of Norco, there will be a savings of $9.12 per 24
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patients. For Dilaudid, the savings would be $25.20 per 24 patients. Fewer adverse effects from
opioids would provide cost savings from less anti-emetic use and urinary catheterization
supplies. Improved pain control may also shorten length of stay, and reduce 30-day
readmissions, yielding further savings for the organization. Preventable surgical readmissions are
associated with increased costs and resource utilization averaging $13,433 per readmission
(Kirkner, 2017). Patients who report severe pain while in the hospital are at a higher risk of painrelated readmission or emergency room visit (Kirkner, 2017). If preoperative gabapentin can
prevent one patient from returning to the hospital for pain-related symptoms, the organization
could save $13,433.
Timeline
The timeline for the project was dependent on the IRB approval from the organization.
The project plan was presented to Spine Team on September 26, 2018. Submission of the IRB
occurred once this university approved this defense on November 10, 2018. The DNP student
provided education to the clinic nurses and pre-procedural services department in November
2018. The ‘go-live’ date was selected for December 1, 2018. The project continued for two
months to gather data from patient electronic health records post-implementation. Data collection
was complete on February 7, 2019, with the graduate statistics student completing statistical
analysis by February 15, 2019. The DNP student will present the final project defense by April
12, 2019 and will disseminate findings to the organization during the Spine Team meeting in
April 2019.
Sustainability Plan
The DNP project was designed to be sustainable. A key part of the project design is
stakeholder support. The neurosurgical team at the organization had already identified pain
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management an integral part of the ERAS program development. The neurosurgeons and
physician assistants are open to new ideas surrounding pain management strategies. Leadership
in the neurosurgical department supports the work of the ERAS team. At the conclusion of this
DNP project, the ERAS team plans to explore other pain management options to create their own
multimodal approach to pain to improve patient outcomes.
This DNP project was implemented strategically to promote sustainability. The
gabapentin order was handwritten onto the surgical boarding slip to ensure ease in compliance.
Administration of gabapentin in the pre-procedural department added little workload for the
providers and the registered nurses, with the potential for significant rewards.
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Figure 1. A model for organizational performance and change. Reprinted from “Institutional and
Organizational Performance Assessment,” by Universalia, 2018, Retrieved online
http://www.universalia.com/en/services/institutional-and-organizational-performanceassessment. Copyright 2018 by Universalia.
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Strengths
Spine Team collaboration with other
departments.
MSSIC member.
Surgeons/physician assistants
recognize the opioid epidemic and are
open to evidence-based practice
change in pain management.
Palliative care team available for
inpatient pain management.

Opportunities
ERAS subcommittee in place.
Decrease opioid use consistent with
recent Michigan legislation.
Improve patient experience scores via
reduced pain.
Reduce post-operative complications
and length of stay related to pain and
immobility.

•
•
•

•
•
•
•
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Weaknesses
High utilization of opioid medications
post-operatively.
Palliative care does not continue
consults after discharge from the
hospital.
Inadequate pain control and reduced
mobility related to pain leads to longer
length of stay.

Threats
Opioid use pre-operative is common.
Neuropathic pain is difficult to
manage.
Lost revenue from longer length of
stay for uncontrolled pain.
Less efficient due to MAPS review
and frequent prescription refills (one
week only).

Figure 2. SWOT analysis of the neurosurgery program

Appendix C

Identification

PRISMA Flow Diagram of Systematic Search
Articles identified using keywords searching in 3 databases
CINAHL (16), PubMed (35), Web of Science (94)
(n = 145)

Eligibility

Screening
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Articles after duplicates removed
(n = 99)
Articles excluded
47 articles prior to 2013
40 articles not metaanalysis/systematic reviews
(n = 87)

Full-text articles assessed for eligibility
(n = 12)

Included

Full-text articles excluded, with
reasons including
2 wrong topics
5 not specific to spine surgery
1 Pregabalin only
(n = 8)
Studies included in this review
• Meta-analysis (2)
• Systematic Review/Metaanalysis (2)
(n = 4)

Figure 3. Flow diagram of search selection process. Adapted from “Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement,” by D. Moher, A. Liberati, J.
Tetzlaff, D. Altman, and PRISMA Group. Copyright 2009 by PLoS Medicine
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Appendix D
Table of Evidence

Table 1. Articles included in review with author, year, purpose, design, inclusion, results, conclusions
Author (Year)
Purpose
Han et al. (2017)
Assess the
efficacy of the
pre-emptive use
of gabapentin in
spinal surgery

Design (N)
Meta-analysis
of
randomized
control trials
(N=10)

Inclusion
Criteria
English
language;
gabapentin vs.
placebo;
reported
outcomes
contained either
cumulative
consumption of
morphine
equivalents at
24 hours, pain
assessment
score, or
incidence of
adverse effects

Intervention vs
Comparison
Gabapentin vs.
placebo

Results

Conclusion

Efficacy:
• Cumulative consumption of
morphine equivalents at 24 hours:
3 studies showed a positive effect
in reduction of morphine
equivalents consumed at 300 mg
dose (mean difference = -1.74 [2.55, -0.93] p < 0.00); 3 studies
showed significant reduction of
morphine equivalents consumed at
600 mg dose (mean difference = 5.36 [-6.27, -4.45] p < 0.00); 4
studies showed positive effect in
reduction of morphine equivalents
consumed at 900 mg dose (mean
difference = -11.41 [-19.75,
3.08] p < 0.00); 4 studies showed
positive effect in reduction of
morphine equivalents consumed at
1,200 mg dose (mean difference =
-17.84 [-28.20, -7.47] p <0.00)
• Pain assessment score: 5 studies
showed gabapentin reduced VAS
scores at 2 hours compared to
placebo (mean difference = -15.16
[-23.75,
-6.58] p < 0.00); 4
studies showed gabapentin reduced
VAS scores at 4 hours compared to

Compared with
placebo, preoperative
gabapentin could
reduce cumulative
morphine equivalents
consumed at 24
hours postoperatively with
reduced pain scores,
and reduced adverse
effects including
vomiting, pruritis,
and urinary retention.
Higher doses of
gabapentin resulted
in less morphine
equivalents
consumed. There
was an increase of
somnolence in the
gabapentin group.
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placebo (mean difference = -15.96
[-24.47,
-7.44] p = 0.0002); 11
studies showed gabapentin reduced
VAS scores at 6 hours compared to
placebo (mean difference = -14.32
[-20.79,
-7.85] p < 0.00); 6
studies showed gabapentin reduced
VAS scores at 12 hours compared
to placebo (mean difference = 11.64 [ -15.76, -7.53] p < 0.00);
11 studies showed gabapentin
reduced VAS scores at 24 hours
compared to placebo (mean
difference = -8.78 [-11.76,
5.80] p < 0.00)
Adverse Effects:
• Nausea: 8 studies showed no
positive association between
gabapentin and placebo (RR = 0.77
[0.55, 1.07] p = 0.12)
• Vomiting: 12 studies showed the
incidence rate was less in the
gabapentin group (RR = 0.53
[0.32, 0.86] p = 0.01)
• Headache: 7 studies showed no
positive association between
gabapentin and placebo (RR = 0.88
[0.45, 1.73] p = 0.71)
• Dizziness: 7 studies showed no
positive association between
gabapentin and placebo (RR = 1.08
[0.68, 1.72] p = 0.75)
• Somnolence: 7 studies showed a
positive effect of gabapentin (RR =
2.52 [1.36, 4.67] p = 0.0003)
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•

Liu et al. (2017)
Determine the
efficacy and
safety of preoperative use of
gabapentinoids
(gabapentin and
pregabalin) for
acute
postoperative
pain following
spine surgery

Meta-analysis
of
randomized
controlled
trials
(N = 16)

Adults
undergoing
lumbar fusion,
lumbar
laminectomy, or
lumbar
discectomy;
compared
gabapentinoids
vs. placebo;
reported
outcomes
contained VAS
at 6,12, and 24
hours, and
complications

Gabapentinoids
vs. placebo

Pruritis: 4 studies showed the
incidence rate was less in the
gabapentin group (RR = 0.38
[0.22, 0.66] p = 0.00)
• Urinary retention: 4 studies
showed the incidence rate was less
in the gabapentin group (RR =
0.57 [0.34, 0.98] p = 0.04)
Efficacy:
• Cumulative consumption of
morphine equivalents at 24 hours:
Pooled results showed
gabapentinoids reduce cumulative
consumption of morphine
equivalents at 24 hours (weighted
mean difference = -18.55 [-23.52,
-13.57] p = 0.000)
• Pain assessment score: 16 studies
showed VAS scores at 6 hours
were reduced in the gabapentinoid
group (weighted mean difference =
-10.57
[-14.52, -6.63] p =
0.20); 16 studies showed VAS
scores at 12 hours were reduced in
the gabapentinoid group (weighted
mean difference = -9.29
[11.74, -6.85] p = 0.000); 16 studies
showed VAS scores at 24 hours
were reduced in the gabapentinoid
group (weighted mean difference =
-7.19
[-10.45, -3.93] p =
0.000)
Adverse Effects:
• Sedation: 16 studies showed no
differences between groups (RR =
1.29 [0.73, 2.28] p = 0.541)

Preoperative
gabapentinoids were
able to reduce postoperative pain, total
morphine equivalents
consumed, and
morphine-related
complications
following spine
surgery. Significant
decreases in risk of
nausea, vomiting,
and pruritis was
associated with
gabapentinoid use.
High dose of
gabapentinoids were
superior to low dose
in reducing acute
pain and cumulative
morphine equivalents
consumed following
spinal surgery.
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•

Peng et al.
(2017)
Determine the
efficacy and
safety of
gabapentin for
pain

Meta-analysis
of
randomized
controlled
trials (N = 7)

Lumbar fusion,
lumbar
laminectomy,
and lumbar
discectomy
surgeries;
reported

Gabapentin vs.
placebo

Dizziness: 16 studies showed no
differences between groups (RR =
1.44 [1.05, 1.99] p = 0.086)
• Headache: 16 studies showed no
differences between groups (RR =
1.10 [0.70, 1.73] p = 0.431)
• Visual disturbances: 16 studies
showed no differences between
groups (RR =1.76 [0.76, 4.04] p =
0.142)
• Somnolence: 16 studies showed no
differences between groups (RR =
1.45 [0.90, 2.34] p = 0.142)
• Urinary retention: 16 studies
showed no differences between
groups (RR = 0.61 [0.38, 0.97] p =
0.42)
• Nausea: 16 studies showed
reduced occurrence in the
gabapentinoid groups (RR = 0.69
[0.54, 0.88] p = 0.004)
• Vomiting: 16 studies showed
reduced occurrence in the
gabapentinoid groups (RR = 0.51
[0.34, 0.76] p = 0.004)
• Pruritis: 16 studies showed
reduced occurrence in the
gabapentinoid groups (RR = 0.34
[0.22, 0.55] p = 0.001)
Efficacy:
• Cumulative consumption of
morphine equivalents at 24 hours:
Pooled results from 6 studies
showed gabapentin can reduce
cumulative consumption of
morphine equivalents (standard

Gabapentin was
efficacious in
reducing postoperative pain, total
morphine equivalents
consumed, and
morphine-related
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management
following spinal
surgery

outcomes
contained VAS
at 12 and 24
hours, total
morphine
equivalents
consumed, and
related
complications
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mean difference = -2.04 [-2.71,
-1.37] p = 0.000)
• Pain assessment score: 3 studies
showed VAS scores at 12 hours
were reduced in the gabapentin
group (weighted mean difference =
-11.18 [-13.85,
-8.52] p =
0.000); 3 studies showed VAS
scores at 24 hours were reduced in
the gabapentin group (weighted
mean difference = -9.94 [-13.99,
-5.89] p = 0.000)
Adverse Effects:
• Nausea: 4 studies showed
significant differences in
occurrence (RR = 0.74 [0.49, 1.12]
p = 0.157)
• Dizziness: 3 studies showed
significant differences in
occurrence (RR = 1.56 [0.93, 2.61]
p = 0.094)
• Somnolence: No studies showed
significant differences in
occurrence (RR = 1.57 [0.66, 3.74]
p = 0.308)
• Headache: No studies showed
significant differences in
occurrence (RR = 0.88 [0.45, 1.73]
p = 0.709)
• Pruritis: 4 studies showed
Gabapentin reduced occurrence
(RR = 0.38 [0.22, 0.66] p = 0.001)
• Urinary retention: Gabapentin
showed reduced occurrence (RR =
0.57 [0.34, 0.98] p = 0.041)

complications
following spine
surgery. A high dose
900 mg or greater is
more effective than a
lower dose under 900
mg.
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•

Yu et al. (2013)
Determine the
efficacy of
gabapentin and
pregabalin in the
management of
post-operative
pain after lumbar
surgery

Systematic
review and
Meta-analysis
of
randomized
control trials
(N = 7)

18 years or
older with
elective lumbar
spinal surgery;
English
language;
reported
outcomes
contained
postoperative
consumption of
morphine
equivalents,
pain score after
surgery 0 to 6
hours, pain
score after
surgery 6 to 12
hours, pain
score after
surgery 12 to 24
hours

Gabapentin (N =
7) or pregabalin
(N = 2) vs.
placebo (one trial
compared
gabapentin,
pregabalin, and
placebo)

Vomiting: Gabapentin showed
reduced occurrence (RR = 0.46
[0.27, 0.78] p = 0.004)
Efficacy:
• Cumulative consumption of
morphine equivalents: Gabapentin
can significantly reduce postoperative opiate consumption
(standard mean difference = -1.54
[-2.43, -0.64] p = 0.001);
pregabalin can significantly reduce
post-operative opiate consumption
(standard mean difference =
1.16 [-1.71, -0.62] p = 0.0001)
• Pain assessment score: 4 studies
showed gabapentin can
significantly reduce post-operative
pain scores at 0-6 hours (standard
mean difference = -1.91 [-2.62, 1.20] p = 0.0001); 4 studies
showed pregabalin can
significantly reduce post-operative
pain scores at 0-6 hours (standard
mean difference = -1.05 [-1.59, 0.51] p = 0.0001); 4 studies
showed gabapentin can
significantly reduce post-operative
pain scores at 6-12 hours (standard
mean difference = -1.30 [-2.00, 0.61] p = 0.0001); 4 studies
showed pregabalin can
significantly reduce post-operative
pain scores at 6-12 hours (standard
mean difference = -0.62 [-1.14, 0.10] p = 0.016); 4 studies showed
gabapentin can significantly

Gabapentin was
efficacious in the
management of postoperative pain at all
time points during
the first day after
surgery and could
significantly reduce
opiate consumptions.
Doses of 600mg,
900mg, or 1200mg
were all considered
effective and safe.
Pregabalin was also
efficacious, but more
trials are needed.
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reduce post-operative pain scores
at 12-24 hours (standard mean
difference = -1.05 [-1.64, -0.46] p
= 0.0001); 4 studies showed
pregabalin seemed to be able to
reduce post-operative pain scores
at 12-24 hours (standard mean
difference = -0.43 [-0.95, 0.08] p =
0.097)
Adverse Effects:
• Not reported
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Appendix E
PARiHS Continua of Dimensions

Figure 4. Adapted from “Enabling the implementation of evidence-based practice: a conceptual
framework,” by A. Kitson, G. Harvey, and B. McCormak. Copyright 1998 by Quality and Safety
in Health Care.
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Appendix F
Iowa Model of Evidence-Based Practice to Promote Quality Care

Figure 5. Adapted from “The Iowa model of evidence-based practice to promote quality care,”
by M. G. Titler et al. Copyright 2001 by Critical Care Nursing Clinics of North America.
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Appendix G
SBAR Education for Staff

Pre-op Gabapentin for Lumbar Surgery Patients
Situation
Patients undergoing lumbar spine surgery including laminectomy with or without fusion experience
significant pain in the post-operative period. Opioid medications are commonly used to help control
post-operative pain, but can lead to unacceptable adverse effects including sedation, urinary retention,
nausea, and constipation. Alternative strategies in managing pain in the immediate post-operative
period is essential to decrease adverse effects of opioids while controlling patient reported pain.
Background
The neurosurgery department formed an Enhanced Recovery After Surgery (ERAS) team in January
2018. Patient reported pain in the post-operative period was identified by the ERAS team as an area
with opportunity to improve. The aim of the ERAS team is to identify alternative strategies to manage
pain that does not include high doses of opioid medications.
Assessment
Currently, opioid medications are the mainstay of treatment for patients following lumbar spine
surgeries. Research of current evidence-based practices show that administering gabapentin preoperatively may reduce pain in the first 24 hours following surgery. Evidence also shows that preoperative gabapentin use may decrease opioid use leading to less sedation, urinary retention, nausea,
and pruritis. Utilizing gabapentin in the pre-operative period is common practice to other ERAS
protocols including colorectal and orthopaedic surgeries.
Recommendation
Patients undergoing lumbar spine surgery with or without fusion will receive one dose of 900 mg
gabapentin one hour prior to surgery. Exclusions are as follows:
1. Patients who already take gabapentin or pregabalin are instructed to take their home dose prior
to arrival to the hospital and will not receive a pre-op dose.
2. Patients with a creatinine clearance below 30 mL/min will not receive gabapentin.
The neurosurgery provider will place the order for gabapentin upon patient arrival to pre-procedural
services.
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Appendix H
Pasero Opioid-induced Sedation Scale

Figure 6. Adapted from “Comparison of selected sedation scales for reporting opioid-induced
sedation assessment,” by A. T. Nisbet & F. Mooney-Cotter. Copyright 2009 by Pain
Management Nursing.
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Appendix I
Budget for DNP Project
Doctor of Nursing Practice Project Financial Operating Plan
Effectiveness of Perioperative Gabapentin for Pain Management in Lumbar Spinal Surgery
Revenue
Project Manager Time (in-kind donation)
Consultations
Statistician (in-kind donation)
Revenue Source
One less dose of Dilaudid given per patient
One less dose of Norco given per patient
One less readmission for pain control
TOTAL INCOME
Expenses
Project Manager Time (in-kind donation)
Team Member Time:
Clinical Nurse Specialist
Consultations
Statistician (in-kind donation)
Cost of Gabapentin
TOTAL EXPENSES
Net Operating Plan

2,520.00
100.00
25.20
9.12
13,433.00
16,087.32

2,520.00
120.00
100.00
3.36
2,743.36
13,343.96
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Structured Abstract
Background: Spinal surgeries are among the top procedures responsible for the highest degree
of post-surgical pain. The opioid epidemic and health care legislation necessitate alternative
strategies in managing pain. The purpose of this quality improvement project was to determine if
preoperative gabapentin improves pain and reduces opioid use after lumbar spine surgery.
Objectives: To evaluate the effectiveness of a single 900 mg dose of gabapentin to impact postoperative opiate use, patient perception of pain, and length of stay in lumbar spine surgery
patients.
Methods: Quality improvement evidence-based project at a hospital in the Midwestern United
States. Gabapentin was administered to patients who are gabapentin naïve one hour prior to
lumbar spine surgery. Opioid use, patient reported pain, length of stay, adverse effects, and
readmissions were compared to determine effectiveness.
Results: Three groups were compared: received gabapentin; qualified, but did not receive; did
not qualify. No differences between groups were found in all outcome measures. No adverse
effects of gabapentin were noted.
Conclusions: Preoperative gabapentin use as a solo intervention did not impact patient reported
pain, opioid use, or length of stay.
Implications: A larger sample will assist in usefulness of gabapentin as a solo intervention for
pain. Further study is needed for the role of gabapentin in a multimodal pain regimen.
Keywords: Lumbar Spine Surgery, Pain Management, Gabapentin, Preoperative
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Introduction
Use of opioid medications for pain management has grown exponentially in recent years,
leading to unprecedented rates of substance abuse, overdose, and death (National Institute on
Drug Abuse [NIDA], 2018). This opioid epidemic results in an estimated 115 American deaths
daily from opioid overdose, with prescription opioid misuse costing the United States 78.5
billion dollars yearly on healthcare costs, loss of productivity, treatment for addiction, and
criminal justice costs (NIDA, 2018). Changes in legislation limits prescribing opioid medications
in outpatient and inpatient settings. Restricting opioid prescribing impacts acute care providers in
managing post-operative acute pain.
Acute care hospitals are challenged in treating acute pain following surgical procedures
for a multitude of reasons. Post-operative pain can be complicated by complex procedures,
patient co-morbidities, and pre-existing opioid tolerance. Recent studies have shown that 30-60%
of patients continue to use opioids after the acute phase of healing following spine surgery (Deyo
et al., 2018). Opioid naïve patients are at substantial risk of becoming a long-term opioid user
with more patients receiving long-term opioids after spine surgery than before surgery (Deyo et
al., 2018). The cumulative dose of opioids prescribed in the first 30 days after surgery strongly
predicts long-term post-operative opioid use (Deyo et al., 2018). Seeking alternative strategies to
manage acute post-operative pain is essential.
Spine surgeries are among the top six procedures responsible for the highest degree of
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post-surgical pain (Bajwa & Haldar, 2015). Up to 50% of patients experience inadequate pain
control leading to dissatisfaction and poor mobility, while almost 25% are given excessive
opioids resulting in suboptimal outcomes and adverse events (Rivkin & Rivkin, 2014). The
inflammatory cascade and resulting post-operative pain begin before the patient wakes up from
surgery (Rivkin & Rivkin, 2014). Strategies in managing acute post-operative pain should be
implemented prior to the onset of the activation of these various pain mechanisms. Pre-emptive
analgesia is administration of pain medication in the perioperative period with the purpose of
providing a preventive effect against pain (Devin & McGirt, 2015). Effective perioperative pain
control is associated with improved surgical outcomes, reduced hospital length of stay, and
decreased development of new chronic pain conditions (Devin & McGirt, 2015).
Opiate pain medications have been the mainstay of treatment for post-operative pain in
spinal surgery. Although effective for acute pain, opioid use has shown to prolong hospital
length of stay related to side effects including respiratory depression, sedation, post-operative
nausea and vomiting, urinary retention, and ileus (Tan, Law, & Gan, 2015). Adverse events
related to opioid use also drives up medical costs and increases readmission rates (Tan et al.,
2015). Inadequate pain control is the second most common reason for 30-day readmissions
following lumbar spine surgery (Kurd, Kreitz, Schroeder, & Vaccaro, 2017). Adequately
managed pain improves functional outcomes, leads to early ambulation, early discharge, and
prevents the development of chronic pain (Bajwa & Haldar, 2015). Treatment strategies in this
patient population are complex, as many already suffer from pre-existing chronic pain with long
term consumption of analgesics and opioids, altering pain perceptions in these patients (Bajwa &
Haldar, 2015).
Multimodal approaches to post-operative pain management have been investigated. Use
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of opiate pain medication is effective in initially controlling acute pain, but subsequent tolerance
and a reduction in pain threshold develop rapidly resulting in an opioid-induced hyperalgesia
requiring higher doses of opiate medications, worsening the potential for adverse effects from
opioid use and further increases sensitivity to pain (Tan et al., 2015). Enhanced Recovery After
Surgery (ERAS) programs have been developed to address factors that delay post-operative
recovery and prolong hospital stay, including pain management (Tan et al., 2015). Research has
shown that multimodal analgesia, using more than one analgesic modality, is effective in
achieving pain control while limiting opioid-related side effects (Tan et al., 2015). In spine
surgeries, ERAS multimodal nonopioid analgesics used in the perioperative stage include various
combinations of medications including gabapentin, pregabalin, acetaminophen, dexamethasone,
ketamine, and nonsteroidal anti-inflammatory drugs (Rivkin & Rivkin, 2014). Used preemptively, these medications act to inhibit central autonomic hyperactivity, thus preventing pain
(Ali et al., 2018). Because standard ERAS protocols for pre-emptive analgesia are multimodal, it
is difficult to determine the benefits and adverse effects for each combination of medicines used
(Tan et al., 2015).
Gabapentin is a second-generation anticonvulsant medication used to treat chronic
neuropathic pain by reducing neuronal excitability while sparing normal physiologic pain
transmission (Devin & McGirt, 2015). The effect of gabapentin is most pronounced after nerve
or tissue injury (Devin & McGirt, 2015). Side effects of gabapentin include dizziness,
somnolence, fatigue, and ataxia (Epocrates, 2018). Contraindications include hypersensitivity to
gabapentin, renal impairment, and alcohol or drug abuse (Epocrates, 2018). Preoperative
gabapentin has been integrated into ERAS programs in a multimodal approach to improve pain
control and limit opioid use. Pre-emptive multimodal analgesia including gabapentin has
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demonstrated improvement in acute post-operative pain, activity, depression and anxiety, and
self-care while reducing opioid use at two weeks following surgery (Ali et al., 2018). The
purpose of this quality improvement project is to implement an evidence-based intervention
utilizing preoperative gabapentin to reduce opioid consumption and improve patient perception
of pain in the first 24 hours post lumbar spine surgery.
Methods
A review of the literature was conducted to examine current evidence using the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline (Moher,
Liberati, Tetzlaff, Altman, & PRISMA Group, 2009). A comprehensive electronic search
conducted in CINAHL, PubMed, and Web of Science was limited to reviews in the English
language from 2013 to 2018. Keywords included gabapentin, spin*, preoperative, preventive,
and pre-emptive. Similar search terms preoperative, preventive, and pre-emptive were listed by
using Boolean operator OR, and the Boolean operator AND was used to narrow articles that are
relevant to the review. Spin* (wild card) was used to include words such as spine and spinal.
Four articles including two meta-analysis and two systematic reviews and meta-analysis
representing 40 randomized control trials on preoperative gabapentin administration from peerreviewed journals were found (see Figure 1). Findings suggest that administration of
preoperative gabapentin is beneficial in improving acute pain experienced by patients within the
first 24 hours post-operatively following spine surgery and reduce opioid use for severe postoperative pain (Han et al., 2017; Liu et al., 2017; Peng et al., 2017; Yu et al., 2013). Adverse
effects are minimal. Including gabapentin in perioperative care of patients undergoing lumbar
spine surgery is strongly supported in the literature to be safe and effective for improving surgery
outcomes.
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The dose of gabapentin to administer was difficult to discern from this evidence. Higher
doses of gabapentin (600 mg or higher) reflected less opioid use (Han et al., 2017; Liu et al.,
2017; Yu et al., 2013). Peng and colleagues (2017) recommend the dose of gabapentin to be at
least 900 mg for best outcomes. Findings from the literature review were utilized in the design of
the project intervention.
Intervention
An evidence-based practice intervention was created for preoperative administration of
gabapentin in lumbar spine surgeries. Evidence suggests that a single dose of 600-1200 mg of
gabapentin one hour prior to surgery yielded best results. Expert opinion from a neuro-palliative
care physician and pharmacist in the neurosurgery department agreed with the evidence and
recommended a 900 mg dose with inclusion/exclusion criteria for patients with chronic kidney
disease and who were not gabapentin/pregabalin naïve, as those variables were not found in the
literature (X. XXXXXXXX, personal communication, September 4, 2018). The intervention
consists of administering 900 mg of gabapentin one hour prior to surgery to lumbar spine surgery
patients, excluding patients who are already prescribed gabapentin or pregabalin, patients with a
hypersensitivity, and those with a creatinine clearance below 30 mL/min (Epocrates, 2018). The
gabapentin was ordered with the preoperative medications by the neurosurgery clinic during the
preoperative visit, and administered by the registered nurses in pre-procedural services.
Approach
The design of this project was a pre- and post-implementation comparison. Approval of
the project was obtained from Spine Team; an interdisciplinary team consisting of neuroscience
leadership, neurosurgeons, physician assistants, registered nurses, dietician, case managers,
physical therapists, infection control, and pharmacists. Registered nurses in the pre-procedural
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services department and in the neurosurgery clinic received education prior to implementation.
Education was disseminated to the clinic nurses via a Lunch and Learn, and a situation,
background, assessment, recommendation (SBAR) communication tool explaining the
intervention (see Figure 2). The pre-procedural services nurses were educated by their clinical
nurse specialist and given the SBAR communication tool.
Data was collected for two months pre- and post-implementation. Data collection began
after approval from the organization’s Institutional Review Board (IRB). The sample size was
reliant on the number of surgeries scheduled during data collection. Data was directly
documented in the Research Electronic Data Capture (REDCap) platform required from the
organization. Data was then exported to statistical package for the social sciences (SPSS)
software for interpretation by a university graduate statistics student.
Measures
Data was collected via chart review from the Cerner electronic health record.
Demographic measures include patient age, sex, type of surgery (laminectomy versus lumbar
fusion), opioid tolerance, and history of prior lumbar spine surgery. Whether the patient was
already taking gabapentin/pregabalin and if a preoperative dose of gabapentin was given were
measured for compliance. Length of stay was measured by number of minutes the patient spent
on the inpatient unit of the hospital starting at transfer from the post anesthesia recovery unit
until discharge from the hospital. Discharge disposition was categorized into a home discharge or
to a rehabilitation facility.
Pain scores were collected via the numeric rating scale. The numeric rating scale is
widely used in the organization and is proven to be reliable, valid, sensitive to change, and easy
to administer for measuring acute severe pain (Bendinger & Plunkett, 2016). The numeric rating
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scale defines mild pain as a score of one to three, moderate pain score four to six, and severe
pain score seven to 10 (Bendinger & Plunkett, 2016). Each patient reported pain score during the
first 24 hours on in the inpatient unit was collected. Opioid use in the first 24 hours of the postoperative period on the inpatient unit was calculated and measured in total daily morphine
milligram equivalents (MME). This was calculated by the New York City Department of Health
and Mental Hygiene mobile application version 2.0.2. Opioid tolerance is defined as
consumption of at least 60 MME for more than seven days within the prior 14 days (Young,
Lund, Dasgupta, & Funk, 2018). Opioid tolerance was measured as this will likely affect the
daily MME.
Potential complications from opioid and gabapentin use were collected. Post-operative
measures include urinary retention via number of straight catheterizations, sedation via Pasero
Opioid-induced Sedation Scale scores (POSS), and nausea via antiemetic administration
collected during the first 24 hours on the inpatient unit. The POSS has shown adequate validity
and reliability to measure level of sedation during opioid administration for pain management
and is easy to use (Nisbet & Mooney-Cotter, 2009). A POSS score of S-2 is acceptable, and a
score of three or four unacceptable. Readmissions to the emergency department and inpatient
unit within the first 30 days of discharge related to pain and sedation were measured to monitor
for changes in trends of readmissions related to opioid consumption or overuse.
Analysis
The data analysis was completed with the assistance of a graduate statistics student. A
total of 140 charts were reviewed (77 pre-implementation, 63 post-implementation). In the postimplementation group, 34 patients qualified for the intervention with 24 patients receiving the
intervention (70.6% compliance). Differences across all qualitative data points between pre- and
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post-intervention groups were not found to be statistically significant due to the small number of
patients who received the intervention in the post-implementation group (see Table 1).
Therefore, three groups were compared for analysis: patients who received preoperative
gabapentin; patients who qualified for gabapentin but did not receive; and those who did not
qualify. Numerical outcome measures were analyzed via ANOVA comparison between the three
groups. Categorical data utilized Chi Square statistical analysis to compare binary outcomes.
Ethical Considerations
An application for review and approval of this project was submitted to the organization
and to the university’s IRB. The purpose and scope of this project are limited to evidence-based
practice improvement and quality improvement. Health Insurance Portability and Accountability
Act (HIPPA) privacy rules were upheld. Protected health information was collected and stored
securely. No patient identifiable information was collected. No physical, social, psychological,
legal, or economic threats to patients are associated with this project. It was anticipated that the
impact of the project will pose minimal or no risk to participants. All members of the team have
completed human subject’s protection training via the Collaborate Institute Training Initiative
(CITI).
Data collection occurred at the organization to ensure confidentiality and security. Data
was collected from the Cerner electronic health record from a computer provided by the
organization. Data was directly documented in the REDCap platform required from the
organization documenting numbers only. The computer and REDCap program are password
protected. Data was exported to SPSS software for interpretation at the discretion of the graduate
statistics student to identify relationships among opioid use, perception of pain, length of stay,
and potential adverse effects.
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Results
This project was implemented over a period of four months with 140 surgeries analyzed.
Pre-intervention data revealed 41 males and 36 females with post-intervention data reporting 32
males and 31 females. Ten males and 14 females received the intervention, 33 males and 25
females qualified, but did not receive, and 30 males and 28 females did not qualify. The
distribution of age between groups did not significantly differ (see Figure 3). For those who
received the intervention, 14 were laminectomy surgeries and 10 were fusions. The qualified but
did not receive group consisted of 30 laminectomies and 28 fusions, and the did not qualify
group represented 26 laminectomies and 32 fusions. No statistically significant differences in
type of surgery was found between the three groups (Chi Square p = 0.5075). Opioid tolerance
was minimal in all groups with p = 0.2991, and history of prior lumbar surgery was not
statistically significant between groups with p = 0.9286. Demographic data for each treatment
group is presented in Table 2. No significant differences in age, gender, type of surgery, opioid
tolerance, or history of prior surgery between the three groups were found.
Opioid consumption in the first 24 hours after surgery was not significantly different preand post-implementation (see Table 1). The variation in MME between the three treatment
groups are presented in Figure 4. Comparing MME between the three treatment groups yielded
statistical significance (see Table 3). Post hoc analysis indicated the significant difference was
found between those who did not qualify, and those who qualified but did not receive the
intervention (see Table 4). Those who did not qualify used an average of 80.98 MME (standard
deviation [SD] = 60.92) compared to 56.27 MME (SD = 46.15) consumed by those who
qualified but did not receive the intervention (see Table 3). The difference between the mean
MME consumed is 24.71 mg of morphine.
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Patient perception of pain was not significantly affected by the intervention. Comparison
of pre- and post- intervention data in Table 1 reveals insignificant mean pain scores (p = 0.4309).
The between groups comparison in pain scores confirm no significant differences are found (see
Table 3).
Hospital length of stay was not improved with this project. Length of stay was not
statistically different between pre- and post-intervention data (see Table 1). Between groups, the
shortest length of stay was found in the qualified, but did not receive group followed by the
received intervention group (see Table 3). However, length of stay in between group
comparisons were not statistically different (see Table 3).
Categorical outcomes contained adverse effects including presence of acute renal failure,
urinary retention requiring a straight catheterization, antiemetic use, sedation, discharge
disposition, and readmission related to pain or sedation. Chi Square analysis found no significant
differences between the three groups for urinary retention, antiemetic use, discharge disposition,
and readmission related to pain (see Table 5). Although not statistically significant, there were
fewer readmissions related to pain in the received intervention group compared to the qualified
but did not receive group (4% versus 8.6%). Sedation, acute renal failure, and readmission for
sedation were found infrequently in all groups (see Table 5). The zero counts made
approximating with Chi Square distribution unreliable.
Discussion
Compliance for those who qualified to receive gabapentin was 70.6%. There were 34
patients who qualified for preoperative gabapentin during the two months of post-intervention
with 24 patients receiving the medication and 10 patients who did not. Of the 10 patients who
should have received gabapentin, four patients did not have the medication ordered, five patients
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had it ordered correctly, but was not transcribed into the medication administration record by
pharmacy, and one patient received an under-dose of 300 mg due to transcription error. During
implementation one clinic nurse was on medical leave and did not attend the Lunch and Learn
education session which may have impacted compliance. Pharmacy errors were reported to their
department. Education to the pharmacy department was a missed opportunity. Providing the
SBAR education to the pharmacy department may have reduced the number of medication
errors. In the pre-procedural services department, many disciplines are initiating various ERAS
protocols that are not consistent causing confusion for the staff. Pre-procedural services will be
provided a single page tool with all the components of the lumbar spine ERAS protocol.
Results indicate no statistically significant associations between the three groups in all
outcome measures. Preoperative gabapentin did not show to significantly alleviate patient
reported pain or reduce opioid use and length of stay, which were the intended outcomes of this
intervention. There were missed opportunities to determine effectiveness of the intervention with
over 40% of patients qualifying, but not receiving the medication. Gabapentin did not cause
harm nor improve adverse effects related to opioid use. This data contradicts what is found in
current research literature. Reasons for these differences are unknown. The significant difference
in opioid use between the did not qualify and qualified but did not receive groups cannot be
explained by the intervention. The outlier seen in the did not qualify group may have caused the
statistically significant finding when compared to the qualified but did not receive group (see
Figure 4). In all groups, there was large variability in MME use perhaps contributing to
insignificant findings.
The difference in number of readmissions for pain between the received intervention and
the qualified but did not receive groups is clinically significant. Although not statistically
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significant, each patient that does not have to return for pain symptoms is meaningful for
improving patient outcomes, patient satisfaction, and financial viability for the organization.
Preventable surgical readmissions are associated with increased costs and resource utilization
averaging $13,433 per readmission (Kirkner, 2017). During the four months of data collection,
the organization potentially spent $13,433 on readmissions for pain from the received
intervention group, and $67,165 on the qualified but did not receive group. The projected annual
cost for readmission for pain is estimated at $40,299 for the received intervention group and
$201,495 for the qualified but did not receive group (see Table 6). There is a potential for an
estimated annual savings of $161,196 if those who qualified actually received the intervention.
The cost by the organization for one 900 mg dose of gabapentin is $0.14 (X. XXXXX, personal
communication, September 13, 2018). Eighty-two patients qualified for gabapentin during the
four months of data collection costing $11.48 if all patients had received the intervention. A
projected annual cost of gabapentin is $34.44. The overall savings for the organization is
approximated at $161,161.56 annually. The financial benefits of preoperative gabapentin for the
organization are substantial.
Literature findings suggest using gabapentin as part of a multimodal pain regimen for
lumbar spine surgery patients. Perhaps the synergistic effect between gabapentin and other
medications such as acetaminophen, NSAIDs, and others provide a greater impact on patient
reported pain and opioid use than gabapentin alone. The 900 mg dose used in this project was
cultivated from findings from the literature and expert opinion, but variances in appropriate
dosing used in other studies may have impacted the results of this project. Since the cost burden
of gabapentin is minimal with few adverse effects, it is reasonable to consider continuation of
preoperative gabapentin to collect a larger sample size for group comparisons.
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Limitations
Limitations for this project relate to sample size and compliance. The sample sizes in the
data analysis are small with only 24 out of the 140 charts reviewed receiving the intervention.
Gathering data over a longer time period will increase the sample sizes and provide more robust
data to generate reliable conclusions on the impact of preoperative gabapentin on pain control
and opioid use. It is difficult to generalize the data findings from this project without collecting a
larger sample.
Compliance with a change in practice takes time. Unexpected barriers such as medical
leave and pharmacy transcription of written orders were unforeseen during project
implementation. With continued data collection, there will likely be an increase in compliance as
the intervention becomes standard practice.
Conclusion
Seeking alternative therapies for pain management is important as the healthcare system
struggles with opioid use. Administration of preoperative gabapentin to lumbar spine surgery
patients is a useful project, but further study is needed to discern proper dose and usefulness as a
multimodal analgesic regimen. Neuropathic post-surgical pain is challenging to treat requiring
the synergistic effect of multiple interventions. This project is sustainable as the process change
of preoperative gabapentin use becomes standard practice in the neurosurgery and pharmacy
departments.
Implications for Practice and Further Study in the Field
Further work is needed to understand why preoperative gabapentin use for lumbar spine
surgery patients was not effective. This organization will continue to collect patient data to
obtain a larger sample size for comparison of groups to determine if gabapentin does make a
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significant difference on pain symptoms. Gabapentin has not shown to have any adverse effects
reported, and does not carry a financial burden in cost or workload for the neurosurgery clinic,
pharmacy, or pre-procedural services. Continuation of the project for further study is reasonable.
Dissemination of findings from this project to the organization and others is also reasonable. The
organization will need to discern if they wish to continue gabapentin use based on the data from
larger sample sizes. Creating a multimodal analgesic regimen that includes preoperative
gabapentin is logical based on the evidence in the literature. Additional projects in the future
include usefulness of acetaminophen, NSAIDs, intraoperative interventions, and other pain
modalities to improve patient outcomes.

Screening

Identification

Figures

Articles identified using keywords searching in 3 databases
CINAHL (16), PubMed (35), Web of Science (94)
(n = 145)

Articles after duplicates removed
(n = 99)
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Eligibility

Articles excluded
47 articles prior to 2013
40 articles not metaanalysis/systematic reviews
(n = 87)

Full-text articles assessed for eligibility
(n = 12)

Included

Full-text articles excluded, with
reasons including
2 wrong topics
5 not specific to spine surgery
1 Pregabalin only
(n = 8)
Studies included in this review
• Meta-analysis (2)
• Systematic Review/Metaanalysis (2)
(n = 4)

Figure 1. Flow diagram of systematic search selection process. Adapted from “Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA statement,” by D.
Moher, A. Liberati, J. Tetzlaff, D. Altman, and PRISMA Group. Copyright 2009 by PLoS
Medicine

Pre-op Gabapentin for Lumbar Surgery Patients
Situation
Patients undergoing lumbar spine surgery including laminectomy with or without fusion experience
significant pain in the post-operative period. Opioid medications are commonly used to help control
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post-operative pain, but can lead to unacceptable adverse effects including sedation, urinary retention,
nausea, and constipation. Alternative strategies in managing pain in the immediate post-operative
period is essential to decrease adverse effects of opioids while controlling patient reported pain.
Background
The neurosurgery department formed an Enhanced Recovery After Surgery (ERAS) team in January
2018. Patient reported pain in the post-operative period was identified by the ERAS team as an area
with opportunity to improve. The aim of the ERAS team is to identify alternative strategies to manage
pain that does not include high doses of opioid medications.
Assessment
Currently, opioid medications are the mainstay of treatment for patients following lumbar spine
surgeries. Research of current evidence-based practices show that administering gabapentin preoperatively may reduce pain in the first 24 hours following surgery. Evidence also shows that preoperative gabapentin use may decrease opioid use leading to less sedation, urinary retention, nausea,
and pruritis. Utilizing gabapentin in the pre-operative period is common practice to other ERAS
protocols including colorectal and orthopaedic surgeries.
Recommendation
Patients undergoing lumbar spine surgery with or without fusion will receive one dose of 900 mg
gabapentin one hour prior to surgery. Exclusions are as follows:
1. Patients who already take gabapentin or pregabalin are instructed to take their home dose prior
to arrival to the hospital and will not receive a pre-op dose.
2. Patients with a creatinine clearance below 30 mL/min will not receive gabapentin.
The neurosurgery provider will place the order for gabapentin upon patient arrival to pre-procedural
services.

Figure 2. SBAR education for staff.
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Distribution of age
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Figure 3. Distribution of age between groups.
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Distribution of mme
Fp = 0.03963.31
Prob > F 0.0396
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Figure 4. Distribution of morphine milligram equivalents between groups.
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Tables
Table 1.
Comparison of qualitative data pre/post-intervention

Group

N

Variable

Mean

Standard
deviation

Preintervention

77

Age
Length of stay in days
MME
Average pain score

62.84
2.48
63.23
4.82

12.68
1.47
51.07
1.67

Postintervention

63

Wilcoxon two-sample
test p-value

0.6085
0.6928
0.4309
0.6107

Age
61.17
14.00
Length of stay in days
2.41
1.50
MME
72.30
58.04
Average pain score
4.98
2.10
Note. MME = Morphine milligram equivalents. P-value < 0.05 determines significance between
groups.
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Table 2.
Demographics for groups compared in project analysis
Group
N
%
Mean
Received Intervention
Age (years)
Gender
Male
Female
Type of surgery
Laminectomy
Fusion
History of prior surgery
No
Yes
Opioid tolerant
No
Yes

24

Qualified/Did Not Receive
Age (years)
Gender
Male
Female
Type of surgery
Laminectomy
Fusion
History of prior surgery
No
Yes
Opioid tolerant
No
Yes

58

Did Not Qualify
Age (years)
Gender
Male
Female
Type of surgery
Laminectomy
Fusion
History of prior surgery
No
Yes

58

62.75
10
14

41.67
58.33

14
10

58.33
41.67

15
9

62.50
37.50

22
2

91.67
8.33

SD

p-value group comparisons

11.02

0.7974
0.4527

0.5075

0.9286

0.2991

33
25

56.90
43.10

30
28

51.72
48.28

35
23

60.34
39.66

53
5

91.38
8.62

30
28

51.72
48.28

26
32

44.83
55.17

37
21

63.79
36.21

62.72

13.33

61.19

14.19
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Opioid tolerant
No
48
82.76
Yes
10
17.24
Note. SD = Standard deviation. P-value < 0.05 determines significance between groups.
Table 3.

Outcomes data for group comparison
Group

N

Mean

Standard
deviation

F value
group
comparison

p-value
group
comparison

Received intervention
24
MME
60.98
50.30
3.31
0.0396
Pain scores
4.72
2.01
2.09
0.1274
LOS
2.51
1.72
0.76
0.4700
Qualified/did not receive
58
MME
56.27
46.15
Pain scores
4.58
1.72
LOS
2.28
1.48
Did not qualify
58
MME
80.98
60.92
Pain scores
5.27
1.91
LOS
2.61
1.39
Note. MME = Morphine milliequivalents; LOS = Length of stay in days. P-value < 0.05
determines significance between groups.
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Table 4.
Post hoc comparison of morphine milligram equivalents (MME)
Comparison of MME between groups with Tukey adjusted p-values
Did not
qualify
Did not qualify

Qualified/did not
receive

Received intervention

0.0369

0.2745

Qualified/did not receive
Received intervention
Note. P-value < 0.05 determines significance between groups.

0.9299
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Table 5.
Adverse effects outcomes data between groups

Urinary retention
Received intervention
Qualified/did not receive
Did not qualify
Antiemetic use
Received intervention
Qualified/did not receive
Did not qualify

No

Yes

21
55
49

3
3
9

Rehab

POSS
S

POSS
1

POSS
2

Chi square
p-value
0.1882

0.8097
17
44
45

7
14
13

Discharge disposition
Received intervention
Qualified/did not receive
Did not qualify
Readmission related to pain
Received intervention
Qualified/did not receive
Did not qualify

Home

0.2739
22
55
50

2
3
8
0.5193

23
53
51

1
5
7

Sedation
Received intervention
Qualified/did not receive
Did not qualify

0
1
2

Acute renal failure
Received intervention
Qualified/did not receive
Did not qualify

24
58
56

0
0
2

Readmission for sedation
Received intervention

24

0

23
55
54

0
1
0
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Did not qualify

57
56

83

1
2

Note. POSS = Pasero Opioid-induced Sedation Scale; S = Sleep, easy to arouse, 1 = Awake and
alert, 2 = Slightly drowsy, easily aroused. P-value < 0.05 determines significance between
groups.

Table 6.
Estimated annual cost savings for the organization
Group

Number of patients
readmitted for pain
in 4 months

Cost per admission
(x $13,433)

Projected total
annual cost for
readmission for pain

Received intervention

1

$13,433

$40,299

Qualified, did not receive

5

$67,165

$201,495
Savings $161,196
Cost of gabapentin
$34.44
Total annual savings
$161,161.56
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